Pomecins are antifungal ingredients. Initially pursued as pharmaceuticals, they have potential uses in crop protection, personal care and food preservation. However Evolva regards Pomecins as legacy products due to their synthetic method of production, which is not synergistic with our focus on fermentation. There are no current activities by Evolva or third parties around this product.


  • Pharmacodynamics of EV-077 in healthy volunteers

    This peer-reviewed article in the Journal of Thrombosis illustrates the pharmacodynamic effects of EV-077, one of our legacy pharma products. Licensed to Norwegian group Serodus ASA, EV-077 is being developed for diabetic nephropathy, a progressive kidney disease caused by diabetes

More articles

Sign up to receive our
Press Releases!

Sign up